Hagopian Henry III 4
4 · Annovis Bio, Inc. · Filed Aug 31, 2022
Insider Transaction Report
Form 4
Hagopian Henry III
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-29+120,000→ 120,000 totalExercise: $11.55Exp: 2032-08-29→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates.